drugset / Trial / NCT00221481

An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder

NCT00221481

RandomizedSingle-groupSingle-blindTreatment

Summary

This study will evaluate how effective mood stabilizers are in the treatment of bipolar disorder with comorbid alcoholism

Timeline

Start
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule 2500 mg
Subject Olanzapine Small molecule 20 mg

Indications